Search Within

Eric J Sherman

Formats
  1. Meeting Abstract (186)
  2. Journal Article (141)
  3. Review (6)
  4. Correspondence (3)
  5. Editorial (3)
  6. Research Letter (2)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Department of Medicine (343)
  2. Head and Neck Service (343)
  3. Solid Tumor Oncology Division (343)
  4. Radiation Oncology, Department of (202)
  5. Surgery (170)
  6. Survivorship Research (158)

More Groups

People
  1. Nancy Lee (198)
  2. Nadeem Riaz (147)
  3. David Pfister (126)
  4. Sean McBride (111)
  5. Richard Wong (108)
  6. Alan Ho (87)

More People

Years
  1. 2025 (4)
  2. 2024 (36)
  3. 2023 (24)
  4. 2022 (29)
  5. 2021 (21)
  6. 2020 (38)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (94)
  2. Journal of Clinical Oncology (83)
  3. Annals of Oncology (19)
  4. Cancer (16)
  5. Head & Neck (16)
  6. Oral Oncology (8)

More Publications

Publishers
  1. Elsevier Inc. (110)
  2. American Society of Clinical Oncology (85)
  3. Oxford University Press (26)
  4. Wiley Blackwell (26)
  5. John Wiley & Sons, Inc. (16)
  6. American Medical Association (11)

More Publishers

Results (343)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Relief of feedback inhibition of HER3 transcription by RAF and MEK inhibitors attenuates their antitumor effects in BRAF -mutant thyroid carcinomas
    Journal Article

    Montero-Conde, C.; Ruiz-Llorente, S.; Domínguez, J. M.; Knauf, J. A.; Viale, A.; Sherman, E. J.; Ryder, M.; Ghossein, R. A.; Rosen, N.; Fagin, J. A.
    Cancer Discovery (2013)

    Fulltext@MSK | Save
  • A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer
    Journal Article

    Fury, M. G.; Sherman, E.; Ho, A. L.; Xiao, H.; Tsai, F.; Nwankwo, O.; Sima, C.; Heguy, A.; Katabi, N.; Haque, S.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
    Journal Article

    Ho, A. L.; Grewal, R. K.; Leboeuf, R.; Sherman, E. J.; Pfister, D. G.; Deandreis, D.; Pentlow, K. S.; Zanzonico, P. B.; Haque, S.; Gavane, S.; more...
    New England Journal of Medicine (2013)

    Fulltext@MSK | Save
  • Should cetuximab replace cisplatin for definitive chemoradiotherapy in locally advanced head and neck cancer?
    Journal Article

    Riaz, N.; Sherman, E. J.; Fury, M.; Lee, N.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancer
    Journal Article

    Isham, C. R.; Bossou, A. R.; Negron, V.; Fisher, K. E.; Kumar, R.; Marlow, L.; Lingle, W. L.; Smallridge, R. C.; Sherman, E. J.; Suman, V. J.; more...
    Science Translational Medicine (2013)

    Fulltext@MSK | Save
  • A phase II study of temsirolimus/sorafenib in patients with radioactive iodine (RAI)-refractory thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Haque, S.; Korte, S. H.; Smith-Marrone, S.; Xiao, H.; Ghossein, R. A.; Fagin, J. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Efficacy of concurrent cetuximab (C225) versus 5-fluorouracil/carboplatin (5FU/CBDCA) or cisplatin (CDDP) with intensity-modulated radiation therapy (IMRT) for locally advanced head and neck cancer (LAHNSCC)
    Meeting Abstract

    Shapiro, L. Q.; Sherman, E. J.; Koutcher, L.; Setton, J.; Zhang, Z.; Shi, W.; Rao, S. S.; Fury, M. G.; Wolden, S. L.; Kraus, D.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Reacquisition of RAI uptake in RAI-refractory metastatic thyroid cancers by pretreatment with the MEK inhibitor selumetinib
    Meeting Abstract

    Ho, A. L.; Leboeuf, R.; Grewal, R. K.; Sherman, E. J.; Deandreis, D.; Pentlow, K. S.; Tuttle, R. M.; Fury, M. G.; Ricarte-Filho, J. C. M.; Pfister, D. G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A phase I study of everolimus (E) plus weekly cisplatin (CDDP) plus intensity-modulated radiation therapy (IMRT) in head and neck (HN) cancer
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Ho, A. L.; Rao, S. S.; Shen, R.; Korte, S. H.; Lisa, D. M.; Ganly, I.; Katabi, N.; Patel, S. G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • External beam radiation therapy in advanced or recurrent nonanaplastic thyroid cancer: An updated experience
    Meeting Abstract

    Romesser, P.; Riaz, N.; Lian, M.; Shaha, A.; Wong, R.; Sherman, E.; Sabra, M.; Tuttle, M.; Rao, S.; Lee, N. Y.
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save